CXCL10 and cardiomyopathy: In human cardiomyocytes cultures, empagliflozin significantly reduced the release of the interferon (IFN)γ-induced 10 kDa protein (IP-10/CXCL10), a chemoattractant associated with inflammation and development of cardiomyopathy.